with 20x the dosage the body goes into hyper rive and produces 20x more to negate all of the drug? Hard to imagine. They got p of roughly .05 comparing a placebo against another placebo-like dose of 1.5mg sounds like random chance. They basically did not meet objective for the dosage that mattered. To say the trial met objective is a stretch.
Imagine getting a drug that gets rid of the last bit of testosterone and at the same time kills you
I have always wondered whether Zytiga/prednisone is doing harm and it looks like it certainly does.
I see, he must have just been promoted to chief marketing officer which is a level that requires reporting of ownership.
I don't want to dis dendreatic cell vaccines, because dendreon's works, but you have to train the cells in 3 injections and 2 weeks apart on one antigen just like provenge, any shortcut with fewer injections or throwing more antigens in the soup will hurt the outcome as shown in imuc trial. Dendreon data shows that antigen spreading will occur in the patients that respond, and the more spreading correlated with extended survival, and i must emphasize that you must follow dendreons process to get Antigen spreading. As for NWBO phase 2 results, if you do a phase 2 and hand pick a few patients and give them placebo along with the standard of care you will see significant improvement over the larger population of patients treated with standard of care in any disease. As for the CEOs investments in this, it is not too clear, whether she is using the cogent funding to prop up her other big investment in Cogent, which is the real biotech behind NWBO, because for every dollar she put in NWBO, she got several times more funneled into Cogents from all of the secondary offerings in NWBO. IMO if NWBO fails pundits will say that it was the 8 man shell that funded Cogent and either way Linda Powers wins and they will credit her for having the balls to do it. Smart gal!!